| David Lee Murphy, MD | |
|
201 16th Ave E, Seattle, WA 98112-5226 | |
| (206) 326-3000 | |
| (206) 326-2785 |
| Full Name | David Lee Murphy |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 201 16th Ave E, Seattle, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134515729 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD60792178 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Regional Medical Center Everett | Everett, WA | Hospital |
| Harborview Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Sound Emergency Medicine Pc | 5496646754 | 54 |
| The Association Of University Physicians | 0446162697 | 3009 |
News Archive
The American Medical Group Association today announced that the recipient of the 2014 AMGA Acclaim Award is Sharp Rees-Stealy Medical Group for an innovative and integrated method to drive population health using a collaborative, team-based approach.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
Merge Healthcare, a leading health IT solutions provider , today announced a new distribution agreement with Microdata Tecnologia LTDA, a PACS and Medical Imaging Technology manufacturer in Brazil. Under the agreement, Microdata Tecnologia LTDA will have exclusive access to a Portuguese language version of eFilm Workstation, the world's most downloaded software for viewing medical images.
A recent study by researchers in Canada shows how mutations in newly emerging lineages of SARS-CoV-2 may disrupt the sequencing process and thus interfere with this important area of research.
Researchers in Manchester have this week launched an innovative new project working with patients and their families to better understand the causes of rheumatoid arthritis.
› Verified 2 days ago
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
The American Medical Group Association today announced that the recipient of the 2014 AMGA Acclaim Award is Sharp Rees-Stealy Medical Group for an innovative and integrated method to drive population health using a collaborative, team-based approach.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
Merge Healthcare, a leading health IT solutions provider , today announced a new distribution agreement with Microdata Tecnologia LTDA, a PACS and Medical Imaging Technology manufacturer in Brazil. Under the agreement, Microdata Tecnologia LTDA will have exclusive access to a Portuguese language version of eFilm Workstation, the world's most downloaded software for viewing medical images.
A recent study by researchers in Canada shows how mutations in newly emerging lineages of SARS-CoV-2 may disrupt the sequencing process and thus interfere with this important area of research.
Researchers in Manchester have this week launched an innovative new project working with patients and their families to better understand the causes of rheumatoid arthritis.
› Verified 2 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
The American Medical Group Association today announced that the recipient of the 2014 AMGA Acclaim Award is Sharp Rees-Stealy Medical Group for an innovative and integrated method to drive population health using a collaborative, team-based approach.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
Merge Healthcare, a leading health IT solutions provider , today announced a new distribution agreement with Microdata Tecnologia LTDA, a PACS and Medical Imaging Technology manufacturer in Brazil. Under the agreement, Microdata Tecnologia LTDA will have exclusive access to a Portuguese language version of eFilm Workstation, the world's most downloaded software for viewing medical images.
A recent study by researchers in Canada shows how mutations in newly emerging lineages of SARS-CoV-2 may disrupt the sequencing process and thus interfere with this important area of research.
Researchers in Manchester have this week launched an innovative new project working with patients and their families to better understand the causes of rheumatoid arthritis.
› Verified 2 days ago
| Entity Name | Associated Emergency Room Physicians Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861480840 PECOS PAC ID: 7911892054 Enrollment ID: O20040218000447 |
News Archive
The American Medical Group Association today announced that the recipient of the 2014 AMGA Acclaim Award is Sharp Rees-Stealy Medical Group for an innovative and integrated method to drive population health using a collaborative, team-based approach.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
Merge Healthcare, a leading health IT solutions provider , today announced a new distribution agreement with Microdata Tecnologia LTDA, a PACS and Medical Imaging Technology manufacturer in Brazil. Under the agreement, Microdata Tecnologia LTDA will have exclusive access to a Portuguese language version of eFilm Workstation, the world's most downloaded software for viewing medical images.
A recent study by researchers in Canada shows how mutations in newly emerging lineages of SARS-CoV-2 may disrupt the sequencing process and thus interfere with this important area of research.
Researchers in Manchester have this week launched an innovative new project working with patients and their families to better understand the causes of rheumatoid arthritis.
› Verified 2 days ago
| Entity Name | North Sound Emergency Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114937919 PECOS PAC ID: 5496646754 Enrollment ID: O20040324000729 |
News Archive
The American Medical Group Association today announced that the recipient of the 2014 AMGA Acclaim Award is Sharp Rees-Stealy Medical Group for an innovative and integrated method to drive population health using a collaborative, team-based approach.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
Merge Healthcare, a leading health IT solutions provider , today announced a new distribution agreement with Microdata Tecnologia LTDA, a PACS and Medical Imaging Technology manufacturer in Brazil. Under the agreement, Microdata Tecnologia LTDA will have exclusive access to a Portuguese language version of eFilm Workstation, the world's most downloaded software for viewing medical images.
A recent study by researchers in Canada shows how mutations in newly emerging lineages of SARS-CoV-2 may disrupt the sequencing process and thus interfere with this important area of research.
Researchers in Manchester have this week launched an innovative new project working with patients and their families to better understand the causes of rheumatoid arthritis.
› Verified 2 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124270715 PECOS PAC ID: 8325100480 Enrollment ID: O20081224000111 |
News Archive
The American Medical Group Association today announced that the recipient of the 2014 AMGA Acclaim Award is Sharp Rees-Stealy Medical Group for an innovative and integrated method to drive population health using a collaborative, team-based approach.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
Merge Healthcare, a leading health IT solutions provider , today announced a new distribution agreement with Microdata Tecnologia LTDA, a PACS and Medical Imaging Technology manufacturer in Brazil. Under the agreement, Microdata Tecnologia LTDA will have exclusive access to a Portuguese language version of eFilm Workstation, the world's most downloaded software for viewing medical images.
A recent study by researchers in Canada shows how mutations in newly emerging lineages of SARS-CoV-2 may disrupt the sequencing process and thus interfere with this important area of research.
Researchers in Manchester have this week launched an innovative new project working with patients and their families to better understand the causes of rheumatoid arthritis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Lee Murphy, MD 201 16th Ave E, Seattle, WA 98112-5226 Ph: (206) 326-3000 | David Lee Murphy, MD 201 16th Ave E, Seattle, WA 98112-5226 Ph: (206) 326-3000 |
News Archive
The American Medical Group Association today announced that the recipient of the 2014 AMGA Acclaim Award is Sharp Rees-Stealy Medical Group for an innovative and integrated method to drive population health using a collaborative, team-based approach.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
Merge Healthcare, a leading health IT solutions provider , today announced a new distribution agreement with Microdata Tecnologia LTDA, a PACS and Medical Imaging Technology manufacturer in Brazil. Under the agreement, Microdata Tecnologia LTDA will have exclusive access to a Portuguese language version of eFilm Workstation, the world's most downloaded software for viewing medical images.
A recent study by researchers in Canada shows how mutations in newly emerging lineages of SARS-CoV-2 may disrupt the sequencing process and thus interfere with this important area of research.
Researchers in Manchester have this week launched an innovative new project working with patients and their families to better understand the causes of rheumatoid arthritis.
› Verified 2 days ago
Sasha Kaiser, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Kristopher Allen Hendershot, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Dr. Lauren Kristen Whiteside, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-744-8464 | |
Brenda Park, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-368-5762 Fax: 814-537-5677 | |
Rhadika Mccormick Souza, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 925 Seneca St, Seattle, WA 98101 Phone: 206-583-6433 Fax: 206-583-6583 | |
Eleanor Ganz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-598-4955 | |
Dr. Gary H. Somers, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-368-1765 |